NEI
RPRX icon

Northwest & Ethical Investments’s Royalty Pharma RPRX Stock Holding History

Northwest & Ethical Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-47,690
Closed -$1.84M – 598
2025
Q4 		$1.84M Buy
47,690
+1,292
+3% +$49.3K 0.04% 261
2025
Q3 		$1.64M Hold
46,398
– – 0.04% 287
2025
Q2 		$1.67M Buy
+46,398
New +$1.54M 0.04% 273
2024
Q4 		– Sell
-27,746
Closed -$785K – 566
2024
Q3 		$785K Buy
27,746
+1,913
+7% +$53K 0.02% 324
2024
Q2 		$681K Sell
25,833
-1,120
-4% -$31K 0.02% 323
2024
Q1 		$819K Buy
26,953
+21,148
+364% +$623K 0.02% 317
2023
Q4 		$163K Buy
+5,805
New +$160K 0.01% 360
2023
Q3 		– Sell
-18,170
Closed -$559K – 400
2023
Q2 		$559K Buy
+18,170
New +$615K 0.02% 323

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return